Hypertension: all 6,834 studies

Page 42 of 69. Open to participants first (972), then studies with results posted, then the rest; newest registration first within each.

• Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once DailyStatus unknownNCT03067415Phase 2
• Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart FailureStatus unknownNCT03063697
• Respiratory Monitoring During Right HeartStatus unknownNCT03061669
• Effect of Dry-weight Probing Guided by Lung-Ultrasound on Ambulatory Blood Pressure and Arterial Stiffness in Hemodialysis Patients (LUST Sub-Study)CompletedNCT03058874Not applicable
• Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial HypertensionCompletedNCT03057028Phase 1
• Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD)WithdrawnNCT03055234Phase 3
• To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic SclerosisStatus unknownNCT03053739Phase 4
• The Effects of Commercial Air Travel on Patients Suffering From Pulmonary HypertensionStatus unknownNCT03051763
• SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)CompletedNCT03050229Phase 4
• Nocturnal Hypertension and Nocturia in African American MenCompletedNCT03048734
• Fixed Combination for Lipid and Blood Pressure ControlWithdrawnNCT03047538Phase 4
• Health Coaching Based Treatment Versus Usual Treatment of Systemic Arterial Hypertension and ComorbiditiesStatus unknownNCT03046680Not applicable
• Hypertension in Long-Term Care FacilitiesCompletedNCT03046420
• Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.Status unknownNCT03045666Not applicable
• Kidney Disease and Pulmonary HypertensionCompletedNCT03045614
• Using Step Count to Enhance Daily Physical Activity in Pulmonary HypertensionTerminatedNCT03043976Not applicable
• Mechanisms Underlying the Blood Pressure Lowering Effect of SleepCompletedNCT03043963Not applicable
• Changes in Renal Function and Body Composition in Pulmonary HypertensionCompletedNCT03039972
• Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension PatientsCompletedNCT03038451Phase 4
• Hemodynamic Parameters Changes in the Course of Hemodialysis Sessions in Patients With Intradialytic HypertensionCompletedNCT03038165
• New Biomarkers and Difficult-to-treat HypertensionCompletedNCT03034265
• Pulmonary Hypertension in Hypersensitivity PneumonitisCompletedNCT03030807
• Effect of Exercise on Selected Anthropometric,Biochemical and Physiological Variables Among Hypertensive PatientsCompletedNCT03029767Not applicable
• The Multicenter Randomized HYpertension and VALUEs (HYVALUE) TrialCompletedNCT03028597Not applicable
• Sodium Healthy Living ProjectStatus unknownNCT03027791Not applicable
• Postpartum ReadmissionTerminatedNCT03026686
• Effectiveness of a mHealth Intervention for the Treatment of Depression in People With Diabetes or Hypertension in PeruCompletedNCT03026426Phase 3
• Central Blood PressureCompletedNCT03026010
• Retrospective Evaluation of Athens Complete Health Improvement Program (CHIP) DatabaseCompletedNCT03025451Not applicable
• Evaluating Effective Methods for Referral for Smoking Cessation Counseling and High Blood Pressure Follow-upCompletedNCT03020836Not applicable
• Exploring Time-efficient Strategies to Improve Fitness for Surgery in Older AdultsStatus unknownNCT03019146Not applicable
• Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAHWithdrawnNCT03016468Phase 2
• Improving Blood Pressure and Cardiovascular Risk With Resistance Exercise in African AmericansStatus unknownNCT03016351Not applicable
• Emotional Awareness and SElf-regulation for Depression in Patients With Hypertension (EASE) StudyCompletedNCT03013907Not applicable
• Intergenerational Blood Pressure StudyCompletedNCT03013179
• Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPDWithdrawnNCT03012646Phase 2
• Genetic Testing of Monogenic Hypertension in Chinese PopulationStatus unknownNCT03012295
• Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and DyslipidemiaStatus unknownNCT03009721
• A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and HyperlipidemiaCompletedNCT03009487Phase 3
• Observational Study of Azilsartan/Chlorthalidone and Irbesartan/Hydrochlorothiazide in Hypertension and Obesity.CompletedNCT03006796
• Technology for Innovative Monitoring of Cardiovascular Prevention: a RCTStatus unknownNCT03005470Phase 3
• Long-term Cardiovascular Outcomes in Patients With RH and OSA With or Without Treatment With CPAPCompletedNCT03002558
• Intensive Blood PRessure Control in Patients With Acute Type B AortIc DissectionStatus unknownNCT03001739Phase 1
• Neurocognition, Lifestyle Modification, and Treatment Resistant HypertensionCompletedNCT03001427Not applicable
• Acute Effect of Agiotensin-(1-7) in Healthy and Hypertensive SubjectsStatus unknownNCT03001271Early Phase 1
• Effects of Transcutaneous Vagal Nerve Stimulation on Hemodynamics ParametersStatus unknownNCT03000842Not applicable
• Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial HypertensionWithdrawnNCT02999906Phase 3
• Fixed vs Free Dose of ACEi/CCB Combination TherapyCompletedNCT02995954Phase 4
• DASH-Sodium Trial in AdolescentsTerminatedNCT02993458Not applicable
• Participatory Patient Care Planning in Primary CareStatus unknownNCT02992431Not applicable
• The Effect of Antihypertensive Medication Timing on Morbidity and MortalityCompletedNCT02990663Phase 4
• Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)CompletedNCT02988362Phase 1
• Investigating the Use of Genetics to Guide Pharmacologic Therapy for HypertensionStatus unknownNCT02988245Phase 2
• Acute Effects of Different Exercises on Blood Pressure in Hypertensive SubjectsStatus unknownNCT02987452Not applicable
• Controlling Hypertension After Severe Cerebrovascular EventCompletedNCT02982655Not applicable
• Community Based Health Education to Manage Uncontrolled Blood Pressure in Surkhet, NepalCompletedNCT02981251Not applicable
• A Study of Oral Nitrate in Adults With Pulmonary Hypertension With Heart Failure and Preserved Ejection FractionCompletedNCT02980068Phase 1
• Complete Health Improvement Program (CHIP) Risk Reduction/Claims Evaluation ProjectCompletedNCT02977884Not applicable
• Unsupervised Physical Activity in ElderlyCompletedNCT02976506Not applicable
• Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal HypertensionStatus unknownNCT02975323Phase 3
• Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With HypertensionCompletedNCT02973035Phase 4
• Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular HealthStatus unknownNCT02972619Not applicable
• An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential HypertensionWithdrawnNCT02969265Phase 3
• Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)TerminatedNCT02968901Phase 4
• Reversal of Right Ventricular Steatosis in Pulmonary HypertensionWithdrawnNCT02966899Not applicable
• Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic HypotensionTerminatedNCT02963181Early Phase 1
• RAS Peptide Profiles in Patients With Treatment-resistant Arterial HypertensionCompletedNCT02962778
• The Effect of Adding Exercise Training to Optimal Therapy in PAHCompletedNCT02961023Not applicable
• Postprandial Effects of a High Potassium MealCompletedNCT02959931Not applicable
• Physiopathology of Pulmonary Arterial Hypertension: Mechanistic StudiesStatus unknownNCT02959723
• Comparison of Blood Pressure Lowering Effect Between Fimasartan and LosartanStatus unknownNCT02958631Phase 4
• FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With AmbrisentanWithdrawnNCT02958358Not applicable
• MI-BP: mHealth to Improve Blood Pressure ControlCompletedNCT02955537Not applicable
• Clinical Trial to Evaluate the Efficacy and Safety of DP-R212WithdrawnNCT02955368Phase 3
• Latinos Understanding the Need for AdherenceCompletedNCT02955238Not applicable
• Noninvasive Cardiac Output Monitoring in Pulmonary HypertensionCompletedNCT02951104Not applicable
• Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and EntecavirStatus unknownNCT02945982Phase 4
• Treatment of Low-grade Cirrhotic Portal Hypertension Due to Hepatitis B Virus With Fuzheng Huayu and EntecavirStatus unknownNCT02945956Phase 4
• Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential HypertensionCompletedNCT02944734Phase 2
• Effect of Sedation on Intra-abdominal PressureStatus unknownNCT02944292Phase 4
• Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial StiffnessTerminatedNCT02940548Phase 4
• Population Research of Sublingual Microcirculation Data of Patients With Systemic DiseasesCompletedNCT02940275
• Study of Myocardial Interstitial Fibrosis in HyperaldosteronismCompletedNCT02938910
• Effect of Exercise on Endothelial Injury in Hypertensive PatientsCompletedNCT02937922Not applicable
• Subcutaneous Median Nerve Neuromodulation For Drug-Treatment Resistant Hypertension.WithdrawnNCT02926495Not applicable
• Early Precise Diagnosis and Intervention of CPT Based on a Noninvasive 3D-vHPSStatus unknownNCT02925975Phase 4
• Comparison of Topical Analgesic With Saline Rinses in Post Extraction HealingCompletedNCT02921165Phase 4
• A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of PregnancyStatus unknownNCT02920593Phase 4
• A Pilot Randomized Controlled Trial to Reduce Salt Intake Among Hypertensive Young Adults in Hong KongTerminatedNCT02920437Not applicable
• A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male SubjectsCompletedNCT02920047Phase 1
• Randomized Comparison of Ultrasound Versus Radiofrequency Denervation in Patients With Therapy Resistant HypertensionCompletedNCT02920034Not applicable
• Compare the Effects of Telemedicine Approach With Usual Care in Hypertension Management in ChinaStatus unknownNCT02919033Not applicable
• Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant HypertensionCompletedNCT02918305Phase 3
• A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605CompletedNCT02916602Phase 3
• Salt-sensitive Hypertension Study in Lantian CountyStatus unknownNCT02915315
• Changes in Central Arterial Pressure When Comparing Nifedipine/Labetalol for Routine Hypertension Control in PregnancyWithdrawnNCT02912910
• TARGET BP I Clinical TrialActive, not recruitingNCT02910414Phase 3
• CS-03 Pressure-Volume Loop Sub-study With RV Lead PositioningCompletedNCT02909868Not applicable
• Actigraphy in Pediatric Pulmonary HypertensionCompletedNCT02909608
• Noninvasive Perioperative Monitoring of Arterial Stiffness, Volume and Nutritional Status in Stable Renal Transplant RecipientsStatus unknownNCT02908139

← Hypertension overview